...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of cardiac surgery. >Apical closure device for full‐percutaneous transapical structural and valve procedures with large‐sized introducer sheaths: The final preclinical study
【24h】

Apical closure device for full‐percutaneous transapical structural and valve procedures with large‐sized introducer sheaths: The final preclinical study

机译：Apical closure device for full‐percutaneous transapical structural and valve procedures with large‐sized introducer sheaths: The final preclinical study

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

Abstract Background Closed‐chest transapical valve implantations (aortic, mitral, and tricuspid) and cardiac structural procedures requiring large‐sized introducer sheaths cannot be safely performed with the available technology. We tested a self‐expanding apical closure device in a closed‐chest animal model, using large‐sized introducer sheaths and human‐sized animals to establish the technique for future tests in humans. Methods Six human‐sized pigs (mean weight: 89.7?±?3.7?kg) received general anesthesia, intubation, and full heparinization (15,000?IU/animal; expected activated clotting time >200?s). Under fluoroscopy and multimodality imaging guidance with next‐generation fusion imaging prototypes, a 15‐cm long needle and a standard guidewire were percutaneously inserted under the xiphoidal aponeurosis and into the ventricular apex. After the exchange with a stiff guidewire, a 21‐Fr introducer sheath for transapical procedures (outer diameter: 25‐Fr) was placed in the left ventricle through the apex. The self‐expanding closure device was inserted and deployed under fluoroscopic guidance while the 21‐Fr sheath was gently removed. Hemodynamic conditions were monitored for 30?min and then the chest was opened to inspect the closure device and quantify the blood loss in the pericardium. Animals were killed and the hearts were removed and inspected. Results All six apical closure devices were successfully deployed without adverse events. No death, hemodynamic collapse, or cardiac tamponade occurred during the 30‐min?observational period (mean systolic and diastolic pressures: 88?±?11 and 58?±?13?mmHg, respectively; mean heart rate: 60?±?11 beats per minutes). Pre‐ and postdeployment (after protamine administration) mean activated clotting time was 541?±?263 and 217?±?62?s, respectively. The plugs provided good sealing with a mean of 27.2?±?13.86?ml of blood lost in the pericardium. Postmortem inspection showed good plug fixation without myocardial damage. Conclusion This self‐expanding apical closure device successfully sealed the percutaneous access sites made with large‐sized introducer sheaths in human‐sized animals. This preclinical study suggests that transapical valve and structural procedures requiring large‐sized introducer sheaths can be performed percutaneously.

著录项

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号